CONMED Corp. (CNMD)
51.50
-1.33
(-2.52%)
USD |
NYSE |
Nov 06, 16:00
51.45
-0.05
(-0.10%)
After-Hours: 20:00
CONMED Market Cap : 1.538B for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 1.538B |
| November 05, 2026 | 1.578B |
| November 04, 2026 | 1.603B |
| November 03, 2026 | 1.411B |
| November 02, 2026 | 1.392B |
| October 30, 2026 | 1.323B |
| October 29, 2026 | 1.366B |
| October 28, 2026 | 1.367B |
| October 27, 2026 | 1.410B |
| October 26, 2026 | 1.424B |
| October 23, 2026 | 1.477B |
| October 22, 2026 | 1.483B |
| October 21, 2026 | 1.413B |
| October 20, 2026 | 1.427B |
| October 19, 2026 | 1.381B |
| October 16, 2026 | 1.401B |
| October 15, 2026 | 1.414B |
| October 14, 2026 | 1.347B |
| October 13, 2026 | 1.366B |
| October 12, 2026 | 1.360B |
| October 09, 2026 | 1.332B |
| October 08, 2026 | 1.353B |
| October 07, 2026 | 1.326B |
| October 06, 2026 | 1.334B |
| October 05, 2026 | 1.419B |
| Date | Value |
|---|---|
| October 02, 2026 | 1.389B |
| October 01, 2026 | 1.377B |
| September 30, 2026 | 1.386B |
| September 29, 2026 | 1.400B |
| September 28, 2026 | 1.394B |
| September 25, 2026 | 1.361B |
| September 24, 2026 | 1.355B |
| September 23, 2026 | 1.373B |
| September 22, 2026 | 1.384B |
| September 21, 2026 | 1.340B |
| September 18, 2026 | 1.362B |
| September 17, 2026 | 1.383B |
| September 16, 2026 | 1.411B |
| September 15, 2026 | 1.408B |
| September 14, 2026 | 1.391B |
| September 11, 2026 | 1.388B |
| September 10, 2026 | 1.386B |
| September 09, 2026 | 1.407B |
| September 08, 2026 | 1.397B |
| September 04, 2026 | 1.479B |
| September 03, 2026 | 1.482B |
| September 02, 2026 | 1.482B |
| September 01, 2026 | 1.473B |
| August 31, 2026 | 1.495B |
| August 28, 2026 | 1.499B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Globus Medical, Inc. | 9.539B |
| Becton, Dickinson & Co. | 57.71B |
| Abbott Laboratories | 190.39B |
| AngioDynamics, Inc. | 497.64M |
| Alphatec Holdings, Inc. | 1.141B |
Market Cap Related Metrics
| PE Ratio | 21.33 |
| PS Ratio | 1.145 |
| PEG Ratio | 1.239 |
| Price to Book Value | 1.451 |
| Price to Free Cash Flow | 11.83 |
| Price | 51.50 |
| Earnings Yield | 4.69% |
| PEGY Ratio | 1.239 |
| Operating PE Ratio | 72.16 |
| Normalized PE Ratio | 16.62 |